ACTRN12612000544875招募中未知
Pharmacokinetics, pharmacodynamics and pharmacogenomics of busulphan and other agents used in blood or marrow transplantation
The Children's Hospital at Westmead0 个研究点目标入组 300 人开始时间: 2012年5月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •1. Patients of any age receiving IV busulphan and /or other conditioning agents prior to autologous or allogeneic transplantation to treat both malignant and non-malignant disease.
- •2. Patients require adequate venous access preferably with a central venous catheter but will be as per institution’s transplant policy
- •3.Written informed consent
排除标准
- •Those for whom written informed consent cannot be obtained.
研究者
相似试验
招募中
不适用
Pharmacokinetics, pharmacodynamics and pharmacogenetics study of eribulin mesylate in patients with unresectable advanced or recurrent breast cancernresectable advanced or recurrent breast cancerJPRN-UMIN000011693ational Cancer Center Hospital50
招募中
不适用
Pharmacokinetic, pharmacodynamic and pharmacogenetic research on biomarkers in cancer patients with special response to pharmacological therapyMalignancyJPRN-UMIN000011798Medical Oncology / Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine600
尚未招募
不适用
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
招募中
不适用
Examining the pharmacokinetic and pharmacodynamic profile of biperidememory impairmentNL-OMON47428niversiteit Maastricht42
招募中
不适用
Pharmacokinetics and pharmacodynamics of drugs in neonates and children during Cardiopulmonary Bypass.congenital heart disease (CHD)1001039410007510NL-OMON39716Erasmus MC, Universitair Medisch Centrum Rotterdam160